AVADEL PHARMACEUTICALS PLC Quarterly Current Ratio in % from Q1 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Avadel Pharmaceuticals Plc quarterly Current Ratio history and growth rate from Q1 2014 to Q2 2024.
  • Avadel Pharmaceuticals Plc Current Ratio for the quarter ending June 30, 2024 was 310 %, a 42.9% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 310 +93.1 +42.9% Jun 30, 2024
Q1 2024 323 +121 +60.1% Mar 31, 2024
Q4 2023 265 -2.12 -0.79% Dec 31, 2023
Q3 2023 230 -158 -40.7% Sep 30, 2023
Q2 2023 217 -315 -59.2% Jun 30, 2023
Q1 2023 202 -597 -74.8% Mar 31, 2023
Q4 2022 267 -1.09K -80.4% Dec 31, 2022
Q3 2022 388 -1.23K -76.1% Sep 30, 2022
Q2 2022 532 -1.07K -66.8% Jun 30, 2022
Q1 2022 799 -635 -44.3% Mar 31, 2022
Q4 2021 1.36K +384 +39.3% Dec 31, 2021
Q3 2021 1.62K +970 +149% Sep 30, 2021
Q2 2021 1.6K +1.15K +252% Jun 30, 2021
Q1 2021 1.43K +1.13K +380% Mar 31, 2021
Q4 2020 978 +699 +250% Dec 31, 2020
Q3 2020 652 +347 +113% Sep 30, 2020
Q2 2020 456 +141 +45% Jun 30, 2020
Q1 2020 299 -28.1 -8.6% Mar 31, 2020
Q4 2019 279 -23.8 -7.86% Dec 31, 2019
Q3 2019 306 +56.6 +22.7% Sep 30, 2019
Q2 2019 314 +104 +49.1% Jun 30, 2019
Q1 2019 327 +130 +65.7% Mar 31, 2019
Q4 2018 303 +112 +58.5% Dec 31, 2018
Q3 2018 249 +26.9 +12.1% Sep 30, 2018
Q2 2018 211 -50.2 -19.2% Jun 30, 2018
Q1 2018 197 -83.8 -29.8% Mar 31, 2018
Q4 2017 191 -107 -35.8% Dec 31, 2017
Q3 2017 222 -91.9 -29.2% Sep 30, 2017
Q2 2017 261 Jun 30, 2017
Q1 2017 281 Mar 31, 2017
Q4 2016 298 Dec 31, 2016
Q3 2016 314 Sep 30, 2016
Q2 2015 190 +1.76 +0.94% Jun 30, 2015
Q1 2015 190 +26.7 +16.3% Mar 31, 2015
Q4 2014 220 Dec 31, 2014
Q3 2014 212 Sep 30, 2014
Q2 2014 188 Jun 30, 2014
Q1 2014 164 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.